Moleculin Biotech, Inc. Class of Warrant or Right, Outstanding
Moleculin Biotech, Inc. (MBRX) had Class of Warrant or Right, Outstanding of 7.60 million shares as of 2025-12-31, per its 10-K filed 2026-03-18.
Financial Statements › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2026-03-18
- 2025-12-31: Class of Warrant or Right, Outstanding 7.60M shares.
- 2024-12-31: Class of Warrant or Right, Outstanding 312.40K shares; Class of Warrant or Right, Outstanding as first filed 7.81M shares.
- 2023-12-31: Class of Warrant or Right, Outstanding 1.37M shares; Class of Warrant or Right, Outstanding as first filed 1.37M shares.
- 2022-12-31: Class of Warrant or Right, Outstanding 220.19K shares; Class of Warrant or Right, Outstanding as first filed 3.30M shares.
| Period end | Class of Warrant or Right, Outstanding | Class of Warrant or Right, Outstanding as first filed |
|---|---|---|
| 2025-12-31 | 7.60M shares 10-K · filed 2026-03-18 | |
| 2024-12-31 | 312.40K shares 10-K · filed 2026-03-18 | 7.81M shares 10-K · filed 2025-03-21 |
| 2023-12-31 | 1.37M shares 10-K · filed 2025-03-21 | 1.37M shares 10-K · filed 2024-03-22 |
| 2022-12-31 | 220.19K shares 10-K · filed 2024-03-22 | 3.30M shares 10-K · filed 2023-03-22 |
| 2021-12-31 | 3.12M shares 10-K · filed 2023-03-22 | |
| 2020-12-31 | 2.84M shares 10-K · filed 2022-03-24 | |
| 2020-09-30 | 17.01M shares 10-Q · filed 2020-11-12 | |
| 2019-12-31 | 1.79M shares 10-K · filed 2021-03-24 | 10.76M shares 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |